Whitepaper: Antibody capture and analysis
Posted: 12 June 2017 | Tosoh Bioscience | No comments yet
The development and production of antibody biopharmaceuticals and biosimilars require specific chromatographic tools for efficient purification and QC analysis to improve process economics, safety, and time-to-market.
Tosoh resins and columns specifically optimized to meet your needs
Tosoh purification resins and analysis columns have a long set standard in industrial manufacturing of biotherapeutics. Sustained investment in research and development maintains our position at the technological frontier.
Over the past decades, we have brought to market successive generations of resins and columns that anticipate our clients’ evolving needs in response to growing pressures on time-to-market, needs for control of production price, tightened safety controls and increasing titers.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
Related topics
Antibodies, Biopharmaceuticals, Biosimilars, Chromatography, QA/QC, Research & Development (R&D)
